News

The Centenary Institute and the University of Technology Sydney will lead pioneering research into age-related muscle loss, called sarcopenia, with a Dynamic Resilience Program contract from Wellcome Leap.

Researchers have discovered a new way to treat hepatocellular carcinoma (HCC), the most common type of liver cancer and the third leading cause of cancer death worldwide.

Dr Bobby Boumelhem, a dedicated researcher at the Centenary Institute, is on a mission to enhance the quality of life for individuals grappling with liver disease. Diseases such as hepatitis, liver cancer, non-alcoholic fatty liver disease and cirrhosis pose significant health challenges.

Researchers, including Dr Matt Johansen from the Centenary UTS Centre for Inflammation and Professor Phil Hansbro, Director of the Centenary UTS Centre for Inflammation, have discovered that a cancer drug could play an important role in limiting the damaging effects of lung disease in COVID-19 patients.

As a medical research institute deeply committed to improving the health outcomes of all Australians, the Centenary Institute wholeheartedly endorses the principles of voice, treaty, and truth, and gives its full support to the Voice to Parliament.

Researchers, including from the Centenary Institute, have highlighted a potential link between gut microbiota (the collection of bacteria residing in the digestive system) and enduring health problems experienced by individuals who have recovered from COVID-19.

The Centenary Institute has announced the winning images of its 'When Art Meets Science' exhibition with Dr Kieran English earning the top spot in the judged category for his portrayal of T cells, an important part of the immune system.

Dr Jessamy Tiffen, Head of the Centenary Institute’s Epigenetics of Melanoma Program, has been an invited panel guest at a special leadership event hosted by the law firm Jones Day.

Professor Phil Hansbro, Director of the Centenary UTS Centre for Inflammation, has been interviewed on the Good Reading podcast about his recently published book, ‘The Good Gut Anti-Inflammatory Diet’.

The Centenary Institute has pledged its commitment to greater transparency in the use of animals for medical research, becoming a signatory of the Openness Agreement on Animal Research and Teaching in Australia.

Dr Mehdi Sharifi Tabar, a researcher from the Gene and Stem Cell Therapy Program at the Centenary Institute, has been announced as the recipient of the 2023 Kenyon Foundation Inflammation Award.

Discover the kaleidoscopic beauty of life at a cellular level with the Centenary Institute’s ‘When Art Meets Science’ art exhibition, now open at NSW Parliament House.